MILWAUKEE, Oct. 23, 2023 /PRNewswire/ — Ademi LLP is investigating INVO (Nasdaq: INVO) for possible breaches of fiduciary duty and other violations of law in its transaction with NAYA Biosciences.
Click here to learn how to join the action https://www.ademilaw.com/case/invo-bioscience-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
In the transaction, NAYA Biosciences’ shareholders will receive 7.3333 shares of INVO for each share of NAYA Biosciences at closing, for a total of approximately 18,150,000 shares of INVO. Following the closing, the combined company is expected to operate under the name “NAYA Biosciences”. INVO and NAYA shareholders will own approximately 12% and 88%, respectively, of the combined company. INVO insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of INVO’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
If you own INVO common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/invo-bioscience-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
SOURCE Ademi LLP
